Literature DB >> 23683938

LOX-1 ligands containing apolipoprotein B and carotid intima-media thickness in middle-aged community-dwelling US Caucasian and Japanese men.

Tomonori Okamura1, Akira Sekikawa, Tatsuya Sawamura, Takashi Kadowaki, Emma Barinas-Mitchell, Rachel H Mackey, Aya Kadota, Rhobert W Evans, Daniel Edmundowicz, Aya Higashiyama, Yasuyuki Nakamura, Robert D Abbott, Katsuyuki Miura, Akira Fujiyoshi, Yoshiko Fujita, Yoshitaka Murakami, Naomi Miyamatsu, Akemi Kakino, Hiroshi Maegawa, Kiyoshi Murata, Minoru Horie, Kenichi Mitsunami, Atsunori Kashiwagi, Lewis H Kuller, Hirotsugu Ueshima.   

Abstract

OBJECTIVE: The serum level of LOX-1 ligand containing ApoB (LAB) may reflect atherogenicity better than LDL cholesterol (LDLC), total LDL particles and usual measurement of oxidized LDL. The association between LAB and intima-media thickness (IMT) of carotid artery was investigated by ultrasound in US and Japan men.
METHODS: Participants were 297 US Caucasian and 310 Japanese men, aged 40-49 years without past history of cardiovascular disease. Serum LAB levels were measured by ELISAs with recombinant LOX-1 and monoclonal anti-apolipoprotein B antibody.
RESULTS: Serum LAB levels [median (interquartile range), μg/L] were 1321 (936, 1730) in US Caucasians and 940 (688, 1259) in Japanese. For Caucasian men, average IMT was higher in higher LAB quartile, which was 0.653, 0.667, 0.688, and 0.702 mm, respectively (p for trend = 0.02). Linear regression analysis showed serum LAB was significantly associated with IMT after adjustment for LDLC or total LDL particles in addition to other traditional or novel risk factors for atherosclerosis such as C-reactive protein. However, there was no significant relationship between LAB and IMT in Japanese men.
CONCLUSION: Serum LAB, a new candidate biomarker for residual risk, was associated with an increased carotid IMT in US Caucasian men independently of various risk factors; however, ethnic difference should be clarified in the future.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23683938      PMCID: PMC3691341          DOI: 10.1016/j.atherosclerosis.2013.04.023

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  35 in total

1.  Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families.

Authors:  Ming-Lin Liu; Kati Ylitalo; Riitta Salonen; Jukka T Salonen; Marja-Riitta Taskinen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-06-17       Impact factor: 8.311

Review 2.  Role of oxidative modifications in atherosclerosis.

Authors:  Roland Stocker; John F Keaney
Journal:  Physiol Rev       Date:  2004-10       Impact factor: 37.312

3.  Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population.

Authors:  Christa Meisinger; Jens Baumert; Natalie Khuseyinova; Hannelore Loewel; Wolfgang Koenig
Journal:  Circulation       Date:  2005-07-25       Impact factor: 29.690

4.  An endothelial receptor for oxidized low-density lipoprotein.

Authors:  T Sawamura; N Kume; T Aoyama; H Moriwaki; H Hoshikawa; Y Aiba; T Tanaka; S Miwa; Y Katsura; T Kita; T Masaki
Journal:  Nature       Date:  1997-03-06       Impact factor: 49.962

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

6.  Comparison of fatal coronary heart disease occurrence based on population surveys in Japan and the USA.

Authors:  I Saito; A R Folsom; H Aono; H Ozawa; T Ikebe; T Yamashita
Journal:  Int J Epidemiol       Date:  2000-10       Impact factor: 7.196

7.  Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis.

Authors:  Kazutaka Hayashida; Noriaki Kume; Takatoshi Murase; Manabu Minami; Daisuke Nakagawa; Tsukasa Inada; Masaru Tanaka; Akira Ueda; Goro Kominami; Hirofumi Kambara; Takeshi Kimura; Toru Kita
Journal:  Circulation       Date:  2005-08-01       Impact factor: 29.690

8.  Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation.

Authors:  Megumi Honjo; Kayo Nakamura; Kenji Yamashiro; Junichi Kiryu; Hidenobu Tanihara; Leslie M McEvoy; Yoshihito Honda; Eugene C Butcher; Tomoh Masaki; Tatsuya Sawamura
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

9.  Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation.

Authors:  Ling Li; Tatsuya Sawamura; Geneviève Renier
Journal:  Circ Res       Date:  2004-03-04       Impact factor: 17.367

10.  Increased circulating malondialdehyde-modified LDL in the patients with familial combined hyperlipidemia and its relation with the hepatic lipase activity.

Authors:  Kenya Yamazaki; Hideaki Bujo; Kouichi Taira; Naohiro Itou; Manabu Shibasaki; Kazuo Takahashi; Yasushi Saito
Journal:  Atherosclerosis       Date:  2004-01       Impact factor: 5.162

View more
  4 in total

1.  Risk Factors Associated With Increased Carotid Intima-Media Thickness in a Male Population With Chronic Alcohol Consumption: A Prospective Observational Study.

Authors:  Baoge Qu; Tao Qu; Yuanxun Liu; Yiguo Jia; Xinghai Han; Jiliang Su; Hui Wang; Lili Liu; Zhongdong Wang; Yafei Wang; Jindun Pan; Guangying Ren
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

2.  "Benifuuki" Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial.

Authors:  Masahiro Miyawaki; Hiroyuki Sano; Hisashi Imbe; Reiko Fujisawa; Keiji Tanimoto; Jungo Terasaki; Mari Maeda-Yamamoto; Hirofumi Tachibana; Toshiaki Hanafusa; Akihisa Imagawa
Journal:  Nutrients       Date:  2018-07-19       Impact factor: 5.717

3.  A Novel Cell-Free, Non-Fluorescent Method to Measure LOX-1-Binding Activity Corresponding to The Functional Activity of HDL.

Authors:  Akemi Kakino; Yoko Usami; Sayaka Horiuchi; Yoshiko Fujita; Kazuhiko Kotani; Chu-Huang Chen; Tomonori Okamura; Tatsuya Sawamura
Journal:  J Atheroscler Thromb       Date:  2019-04-03       Impact factor: 4.928

4.  Association of circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 with inflammatory markers and urinary albumin excretion in patients with type 2 diabetes.

Authors:  Kohzo Takebayashi; Tatsuhiko Suzuki; Mototaka Yamauchi; Kenji Hara; Takafumi Tsuchiya; Toshihiko Inukai; Koshi Hashimoto
Journal:  SAGE Open Med       Date:  2021-12-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.